“Plants for Joints” lifestyle intervention continues to show long-term benefits in osteoarthritis

Attaining LLDAS and reducing GC use with anifrolumab in SLE patients: The TULIP-LTE study

Impact of ixekizumab on structural lesions in SIJ of patients with r-axSpA: Post-hoc analysis of the COAST-V trial

New insights on the impact of tapering GCs or immunosuppressive therapy on damage accrual after achieving LLDAS and complete remission SLE

Validation of IMACS guidelines for enhanced cancer screening: A Hong Kong myositis cohort